Inside Self-Storage is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

StorageMart Donates $1K to Kure It Cancer Research Through Facebook Challenge

Article-StorageMart Donates $1K to Kure It Cancer Research Through Facebook Challenge

<p>Self-storage operator StorageMart recently donated $1,000 to Kure It Cancer Research, a nonprofit dedicated to funding kidney and other cancer research. Through its charitable arm, StorageMart Gives, the company challenged its Facebook users to like or share the Kure It  logo, promising a donation of $1 (up to 1,000) for each action. The goal was reached in just a few weeks.</p>

Self-storage operator StorageMart recently donated $1,000 to Kure It Cancer Research, a nonprofit dedicated to funding kidney and other cancer research. Through its charitable arm, StorageMart Gives, the company challenged its Facebook users to like or share the Kure It  logo, promising a donation of $1 (up to 1,000) for each action. The goal was reached in just a few weeks.

Thank you for showing your support for our support of kidney cancer research, StorageMart spokesperson Tron Jordheim told the companys Facebook community. We really admire Kure-It founder Barry Hoeven for his vision and efforts to help fund research for cancers that don't get as much publicity. Thanks again to all of you for helping make this donation happen.

Headquartered in Columbia, Mo., StorageMart operates more than 130 locations across the United States and Canada.

Kure It was launched by Barry Hoeven, who was diagnosed with kidney cancer in 1998. In April 2007, Hoeven partnered with cancer center City of Hope to create the Kure It! Kidney Cancer Research Fund, which raised more than $400,000. Kure It Inc. was established in January 2010 as an independent, non-profit 501(c)(3) organization. Its goal is to be the leader in granting funds to cancer researchers investigating progressive treatments and cures.